EASL DeepDive: What is the future of PBC treatment?

In this EASL DeepDive held on 25 February 2025,  Ana Lleo, Adriaan van der Meer, Gideon Hirschfield, and Bettina Hansen explore the future of primary biliary cholangitis (PBC) treatment. Discover the emerging therapies, current challenges and personalised approaches that are shaping the management of PBC. Learning objectives Learn more about the molecular mechanisms underlying the disease and the potential targets for drug therapy Get a good understanding of the efficacy of the current drugs and the potential added value of the upcoming second line treatments for PBC and where to position these new treatments in the treatment landscape Learn more about the evolving concepts regarding the endpoints in clinical trials for PBC Get insights in the risk assessment of people living with PBC and criteria for second line therapy  This EASL DeepDive webinar is supported by Gilead. Gilead has had no input into the content of this EASL DeepDive.